We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A microscope sits in the middle of sets of wires.

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

A white blood cell.

Promising Treatment Approach for Aggressive Leukemia Identified

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

Immune Cells “Remember” the Pain of Newborn Injuries

Neuro-Cognitive Computer Models Make Reading More Efficient

News

Genticel Appoints New Vice-President

Appointment of Dr Gerald Moeller as vice-president of Company’s supervisory board.

TriLink Announces New License Agreement with Biofortuna

Agreement for use of CleanAmp™ dNTPs in Biofortuna’s freeze-drying contract development and production service.

Genetic Aberration Paves the Way for New Treatment of Cancer Disease

Research was recently published in Scandinavian Journal of Gastroenterology.

Earliest Marker for Autism Found in Young Infants

NIH-funded study finds attention to others’ eyes declines in 2 to 6-month-old infants later diagnosed with autism.

NIH-funded Study Finds that Gabapentin may Treat Alcohol Dependence

Promising results from a randomized, controlled clinical trial of the medication.

BBSRC Invests £10 M in Synthetic Biology

The investment has been allocated to the fund by the BBSRC in response to the 2012 Synthetic Biology Roadmap, which sets out plans to harness opportunities in this area.

Immunocore Achieves Research Milestone in GSK Collaboration

Under the agreement announced in July, Immunocore will receive up to £142 million in pre-clinical milestone payments across the targets.

Biocartis Announces Completion of EUR 30 Million Series E Equity Fundraising

Company poised for 2014 commercial launch.

ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics

Adds an additional proprietary ADC development program in oncology.

Repligen Completes Expansion of U.S. Manufacturing Facility

Waltham boost doubles chromatography capacity.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter